Replicate Bioscience Awarded Grant to Advance srRNA Vaccine Candidates for Tuberculosis

Company receives grant from the Gates Foundation to develop srRNA vaccine candidates for tuberculosis, subject to humanitarian licensing terms SAN DIEGO, June 19, 2026 /PRNewswire/ -- Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology...

Read More